British scientists are conducting the first study on the human genome to determine the genetic causes of osteoarthritis.
Our friend, Timothy Spaulding, a Top Health Blogger for the Arthritis Community on Wellsphere and author of the Current Arthritis News and Research Blog explains in his recent article about The Genetic Link to Osteoarthritis.
The two year study will help researchers find and develop drugs to block the genetic mutations that lead to the disease. 30 scientists at eight centers in the UK are currently seeking out 14,000 volunteers for the study, 6,000 healthy people and 8,000 who are awaiting, or have had, joint replacement surgery due to osteoarthritis.
There are half a million distinct regions in human DNA and it is expected that there are at least 100 genes that have a link to increased risk of OA. In fact, osteoarthritis is nearly three times more inheritable than breast cancer.
It is hoped that an outcome of the study, known as arcOGEN, is that within a few years an inexpensive test will be developed to identify people that are most likely to develop OA. Results of the study will be freely shared with other scientists around the world. The project has received is £2.2 million ($4.5 million) from the Arthritis Research Campaign (ARC).
In many cases, Flexcin can help alleviate the pain associated with osteoarthritis. The primary component of Flexcin™ is CM8™ (cetyl myristoleate). Of all the ingredients in Flexcin, CM8™ is the most powerful. CM8™ functions in three different ways. First, it acts as a highly effective lubricant in the joints, muscles and other tissues, allowing them to move smoothly. Decrease or loss of morning stiffness is commonly noted shortly after commencing treatment. Next, CM8™ functions as an anti-inflammatory. Third, it is also an immune system modulator, which can be effectual against autoimmune diseases, such as arthritic conditions. CM8™ relieves joint pain at its source, reducing inflammation and irritation of the joints and tissues.
Read more of Timothy Spaulding’s interesting topics on his Current Arthritis News and Research Blog.
